Home/Filings/4/0001104659-26-006260
4//SEC Filing

Carrabba Joseph A 4

Accession 0001104659-26-006260

CIK 0000101538other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:36 PM ET

Size

8.1 KB

Accession

0001104659-26-006260

Research Summary

AI-generated summary of this filing

Updated

United States Antimony (UAMY) Director Joseph Carrabba Receives Awards

What Happened Joseph A. Carrabba, a director of United States Antimony Corp (UAMY), was granted equity awards on January 15, 2026: 19,903 RSUs of which one‑third (6,635 shares) vested immediately (acquired at $0.00), and a stock option award covering 12,259 shares (reported as a derivative grant). The RSU portion shows an immediate acquisition of 6,635 shares at $0.00 (value reported as $0 in the filing). The option grant is reported as a derivative award; no exercise/strike price or immediate cash proceeds are disclosed in the filing.

Key Details

  • Transaction date: January 15, 2026; Form 4 filed January 23, 2026 (filed ~8 days after the transaction; Form 4 is normally due within 2 business days).
  • RSU: 19,903 total RSUs granted; one‑third (6,635 shares) vested on Jan 15, 2026 and were acquired at $0.00. Remaining RSUs vest one‑third on Jan 15, 2027 and Jan 18, 2028, subject to continued service. (Footnote F1)
  • Option: stock option award covering 12,259 shares; vests in three equal tranches (4,087 shares vesting Jan 15, 2027; then Jan 18, 2028; and Jan 16, 2029), subject to continued service. Strike/exercise price not disclosed in the provided data. (Footnote F2)
  • Shares owned after transaction: Not specified in the provided excerpt of the filing.
  • Filing timeliness: Filing was later than the typical 2‑business‑day Form 4 deadline (filed 8 days after the transaction date).

Context These actions are compensation awards (RSU vesting and an option grant) rather than open‑market purchases or sales; such awards are commonly part of executive/director compensation and do not, by themselves, indicate a personal buy or sell signal. The option grant is a future economic right that vests over time; there is no indication in this filing that options were exercised or that any shares were sold.

Insider Transaction Report

Form 4
Period: 2026-01-15
Transactions
  • Award

    Common Stock

    [F1]
    2026-01-15+6,635112,702 total
  • Award

    Stock Option

    [F2]
    2026-01-15+12,2590 total
    Exercise: $8.29Common Stock (12,259 underlying)
Footnotes (2)
  • [F1]Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 6,635 shares of the 19,903 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.
  • [F2]Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 4,087 shares of the 12,259 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.
Signature
/s/ Joseph Carrabba|2026-01-23

Issuer

UNITED STATES ANTIMONY CORP

CIK 0000101538

Entity typeother

Related Parties

1
  • filerCIK 0001328270

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:36 PM ET
Size
8.1 KB